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Abstract
Background: Implementation of human papillomavirus (HPV) vaccination raised concerns that vaccination could
lead to riskier sexual behavior. This study explored how possible differences in sexual behavior and HPV knowledge
developed over time between HPV-vaccinated and unvaccinated girls.
Methods: A random sample of 19,939 girls (16–17 year olds) eligible for the catch-up HPV vaccination campaign in
the Netherlands was invited for a longitudinal study with questionnaires every 6 months over a two-year follow-up
period. Possible differences over time between vaccinated and unvaccinated participants were studied using generalized
equations estimation (GEE).
Results: A total of 2989 girls participated in round one, of which 1574 participated (52.7%) in the final 5th round.
Vaccinated girls were more likely to live in more urban areas (OR 1.28, 95%CI 1.10–1.47) and to use alcohol (OR 1.46,
95%CI 1.24–1.70) and contraceptives (OR 1.69, 95%CI 1.45–1.97). Vaccinated and unvaccinated girls showed
comparable knowledge on HPV, HPV vaccination, and transmission. Vaccinated girls were more likely to be
sexually active (OR 1.19, 95%CI 1.02–1.39), and this difference increased over time (OR for interaction 1.06, 95%CI
1.00–1.12). However, they had a slightly lower number of lifetime sexual partners (mean difference − 0.20, 95%CI
-0.41-0.00). Vaccinated girls were less likely to use a condom with a steady partner (aOR 0.71, 95%CI 0.56–0.89).
However, the difference between vaccinated and unvaccinated girls with regard to condom use with casual or
steady partner(s) did not significantly change over time.
Conclusion: Overall, we did not find indications that vaccination influenced sexual behavior in girls during 2 years of
follow-up. The few differences found may be related to existing disparities in the socio-demographic characteristics of
the young population pointing to the importance and improvement of education with regard to safe sex practices.
Our findings do not suggest that vaccination status is associated with changes in sexual risk behavior and thus it is
unlikely that this might influence the effectiveness of the vaccination program.
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Background
A persistent infection with a high-risk type of the human
papilloma virus (HPV) is the most important risk factor
for the development of premalignant cervical intrae-
pithelial neoplasia (CIN) and cervical cancer [1]. HPV is
a common sexually transmitted infection (STI), with a
lifetime risk of approximately 80% for acquiring an HPV
infection in both sexually active males and females [2].
In 2009, girls aged 13 to 16 years in the Netherlands
were offered the bivalent HPV vaccine (Cervarix®) during
a “catch-up” vaccination program [3]. The vaccine up-
take (completely vaccinated with a three-dose schedule)
during this “catch-up” campaign was 52.3% [4]. From
2010, HPV vaccination was included in the Dutch Na-
tional Immunization Program for girls in the year they
turn 13 [3]. Implementation of HPV vaccination raised
the concern that a vaccine against an STI might lead to
more and/or riskier sexual behavior by vaccinated ado-
lescents [5]. Although only 3 to 6% of parents in the
United Kingdom stated the above as a reason to refuse
vaccination of their daughters [6, 7], 16 to 26% of par-
ents mentioned having this worry [8–12]. Wilde’s Risk
Homeostasis Theory suggests that individuals anticipate
a lower risk from a certain behavior due to the perceived
benefits of that behavior [13]. In the case of HPV vaccin-
ation, this could imply that vaccinated individuals might
have lower risk perceptions, not only for acquiring HPV,
but also other STIs, and therefore show riskier sexual
behavior. The development of adequate risk perceptions
is related to knowledge regarding HPV and HPV vaccin-
ation [14, 15]. Possible differences in behavior or know-
ledge that exist or may develop over time between
vaccinated and unvaccinated girls might influence the out-
comes of prevention strategies against HPV-associated
diseases [16]. Previous studies exploring sexual behavioral
changes by HPV vaccination were generally small or had a
short follow-up period [12]. These studies observed either
no association for pregnancy and STI rates with HPV vac-
cination [17–20] or a lower rate of Chlamydia trachoma-
tis in the vaccinated group [21]. No association was found
for HPV vaccination with ever had sex [5], the number of
sexual partners [5, 17, 18, 22, 23] or the consistency of
condom use [5, 17, 21, 22]. In this study, we explored to
what extent differences between HPV-vaccinated and un-
vaccinated adolescent girls in sexual behavior and HPV
knowledge developed over time (follow-up of 2 years) in
the Netherlands.
Methods
Study design
Recruitment and methodology of the round one survey
among 16 to 17 year old girls has been described previ-
ously [24]. Briefly, in December 2010, a random sample
of 19,939 girls (both vaccinated and unvaccinated) who
had been eligible for the HPV-vaccination catch-up
campaign in 2009 was invited by post with an informa-
tion letter for herself and for her parents/caretakers to
participate in a longitudinal online semi-structured
questionnaire study [24]. Those consenting to participate
were invited another four times (Rounds 2 to 5: July
2011, February and August 2012, and February 2013) to
answer similar online questionnaires. Reminders and
invitations to participate in these follow-up question-
naires were sent via the online system (EFS Survey ver-
sion 8.1, Unipark (Questback)). This research was
performed in accordance to the principles of the Declar-
ation of Helsinki [25]. Based on the nature of the study,
the Dutch Central Committee on Research Involving
Human Subjects (Centrale Commissie Mensgebonden
Onderzoek (CCMO)) decided that approval from a
medical-ethical review committee was not required for
this study, in agreement with the Dutch Medical Re-
search involving Human Subjects Act. The CCMO
allowed to receive consent through the online system
from the participating girls, no written consent from the
girls or their parents was required [24].
Measures
The used questionnaire contained pre-coded questions
on socio-demographic characteristics (e.g. educational
level, ethnicity, alcohol and smoking behavior), sexual
behavior (e.g. ever had sex and number of partners) and
questions on HPV infection and vaccination, in order to
verify the participants knowledge. Vaccination history of
the participants was obtained from the national vaccin-
ation database Praeventis [26]. Comparable to Mollers et
al., who previously described round one of this study,
composite scores for knowledge, assigning a point for each
correct answer to questions regarding general knowledge
(ten questions), HPV transmission (11 questions), and
HPV vaccination (three questions) were calculated [24].
Questions regarding general HPV knowledge, vaccination
and transmission were only incorporated in rounds one
and five.
Statistical analysis
We examined whether the trend over time in socio-demo-
graphic and sexual risk behavior was different between
vaccinated and unvaccinated girls using generalized esti-
mating equation (GEE) models with an exchangeable cor-
relation structure. For dichotomous outcomes, we used a
binomial GEE model with logit link, resulting in odds ra-
tios (OR) as the measure of association. For continuous
outcomes, a GEE with a normal distribution was used,
resulting in a mean difference. For univariable analyses,
potential risk factors were used as dependent variables,
and vaccination status was used as the independent vari-
able. First, we added time (rounds of interviews, as
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continuous factor) and the interaction between vaccin-
ation status and time as independent variables. Estimates
for interaction between vaccination status and time were
only reported if a significant interaction (i.e. a difference
between vaccinated and unvaccinated changed over time)
was observed. If no significant interaction was observed,
an overall (across all time-points) estimate for vaccination
status was reported. To explore whether a significant
development over time in the two groups occurred, we
stratified the data for vaccinated and unvaccinated
participants for all variables and used time as the
independent variable. Similar analyses were performed
for the questions regarding knowledge on HPV (vaccin-
ation) and transmission, in which the outcome was
‘giving the correct answer’. We adjusted sexual risk be-
havior and condom use in a multivariable GEE model,
correcting for socio-demographic characteristics which
were significantly different between vaccinated and un-
vaccinated participants.. Analyses were performed using
SAS 9.3 (SAS Institute, Inc. 2010, USA).
Results
From 19,939 invited girls, 2989 (15%) participated in
round one of this study. [24] Participation in the follow-
ing rounds was, in chronological order: 2040 (68.3%),
1778 (59.5%), 1789 (59.9%), and 1574 (52.7%) of the
2989 girls who were included in round one.
Participant characteristics and health behavior
The analysis of socio-demographic characteristics, sexual
risk behavior, and HPV knowledge among vaccinated
and unvaccinated girls from the first round of study has
been previously reported [24]. At the start of the study
65% of all participants were vaccinated, participants had
a median age of 17 years, vaccinated participants were
more likely to live in more urbanized areas, to ever have
used alcohol, contraception and to ever had sex. Table 1
shows the univariable longitudinal analysis (using GEE)
of the participant characteristics and health behavior
comparing vaccinated and unvaccinated girls. There was
a significant difference in the degree of urbanization, al-
cohol use, and use of contraceptives between vaccinated
and unvaccinated girls; these differences did not change
over time. Vaccinated girls were more likely to live in
more urbanized areas (OR 1.28, 95%CI 1.10–1.47) and
to have ever used alcohol (OR 1.46, 95%CI 1.24–1.70)
and contraceptives (OR 1.69, 95%CI 1.45–1.97). The per-
centage of sexually active participants increased signifi-
cantly over time in both vaccinated and unvaccinated
individuals, from respectively 56 to 80% and from 52 to
71% (both p < 0.01). Vaccinated girls were more likely
than unvaccinated girls to report ever having sex (OR
1.19, 95%CI 1.02–1.39) in round one, and this difference
increased over time (significant interaction between
vaccination status and time: OR 1.06, 95%CI 1.00–1.12),
reaching an OR of 1.49 (95%CI 1.18–1.87) in round five.
Sexual risk factors among sexually active participants
As none of the interaction terms between time and vac-
cination status were significant for the behaviors re-
ported in Table 2, there was no evidence for a difference
between vaccinated and unvaccinated sexually active
participants in changed sexual behavior. However,
among sexually active participants in both groups, sexual
behavior changed over time compared to round one, as
the lifetime number of partners increased and the per-
centage of participants with a casual partner declined.
The lifetime number of sexual partners was slightly
lower among vaccinated girls (adjusted mean difference
− 0.26, 95%CI -0.46-0.05) (Table 2).
No significant interactions between time and vaccin-
ation status were observed for condom use with casual
and/or steady partners. Condom use with a casual part-
ner did not change significantly over time in vaccinated
or unvaccinated participants. There was no difference in
always using a condom with a casual partner in the pre-
ceding 6 months between vaccinated and unvaccinated
participants (adjusted OR 1.00, 95%CI 0.78–1.27). How-
ever, condom use with a steady partner declined over
time in both vaccinated and unvaccinated participants.
In addition, vaccinated girls were less likely to always
use a condom with a steady partner (adjusted OR 0.71,
95%CI 0.57–0.90). Although a difference in change over
time was observed between vaccinated and unvaccinated
when examining the variable ‘always using condoms’
(OR for interaction 0.91; 95%CI 0.82–1.00), after adjust-
ment for other variables no significant change in differ-
ence (interaction) was observed anymore (OR for
vaccination 0.85; 95%CI 0.70–1.02) (Table 3).
HPV general knowledge
There were no significant differences in general HPV
knowledge score (giving the correct answer) between
vaccinated and unvaccinated participants (mean differ-
ence 0.11, 95%CI -0.02-0.23) (Table 4). In both groups,
the general knowledge score increased significantly
(p < 0.01); however, no differences in change over time
were observed between vaccinated and unvaccinated
girls (no significant interaction).
HPV transmission knowledge
Knowledge of HPV transmission (transmission know-
ledge score) increased significantly over time among
vaccinated girls (p = 0.01), but not among unvaccinated
girls (p = 0.60). However, we did not observe a difference
in transmission knowledge over time between vaccinated
and unvaccinated girls (no significant interaction)
(Tables 5 and 6).
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Knowledge of the consequences of HPV vaccination
In round one, vaccinated participants had a lower overall
knowledge score regarding the effects of HPV vaccination
(mean difference − 0.07, 95%CI -0.12 - -0.01) (Table 6).
However, over time, this difference diminished (inter-
action term between time and vaccination 0.02, 95%CI
0.00–0.04). In round five, there was no significant differ-
ence between vaccinated and unvaccinated girls (mean
difference 0.01, 95%CI -0.04-0.07). In both vaccinated and
unvaccinated participants, the knowledge score regarding
HPV vaccination significantly increased over time.
Discussion
Our main hypothesis was that vaccinated girls might
perceive themselves at a lower risk for contracting STIs
and therefore develop higher risk sexual behaviors, for
instance, by lowering condom use. Although we ob-
served that vaccinated girls were less likely to use a
condom with their steady partner, changes in condom
use over time with both steady and casual partners did
not differ between vaccinated and unvaccinated girls.
Vaccinated girls were more likely to ever have been
sexually active, and this difference increased over time,
but among sexually active participants, we did not
observe noteworthy differences in sexual behavior over
time between vaccinated and unvaccinated girls. Also,
although knowledge of our participants on HPV, HPV
transmission and vaccination was suboptimal, we did
not find major differences between vaccinated and un-
vaccinated girls.
Table 1 Univariable longitudinal analysis (using GEE) of characteristics of participating girls over time
Round 1b Round 2 Round 3 Round 4 Round 5
Category n (%) n (%) n (%) n (%) n (%) p-value OR (+ 95% CI)
Participants
Unvaccinated 1051 (100) 679 (65) 565 (54) 572 (54) 502 (48)
Vaccinated 1938 (100) 1361 (70) 1213 (63) 1217 (63) 1072 (55)
Median age (range)
Unvaccinated 17 (16–17) 17 (17–18) 18 (18–19) 19 (18–19) 19 (19–20)
Vaccinated 17 (16–17) 17 (17–18) 18 (18–19) 19 (18–19) 19 (19–20)
More urban areas (> 1000 inhabitants)
Unvaccinated 495 (47) 315 (47) 278 (49) 308 (55) 282 (57) < 0.01 Ref
Vaccinated 1019 (53) 714 (53) 712 (59) 734 (61) 685 (65) < 0.01 1.28 (1.10–1.47)
Low/Middle Educationa
Unvaccinated 434 (42) 235 (35) 189 (34) 180 (32) 153 (31) 0.10 Ref
Vaccinated 779 (40) 465 (35) 394 (33) 386 (32) 324 (30) 0.07 0.96 (0.83–1.11)
Ever have used alcohol
Unvaccinated 751 (72) 507 (76) 431 (77) 449 (79) 389 (78) < 0.01 Ref
Vaccinated 1509 (78) 1107 (82) 988 (82) 1021 (84) 888 (83) < 0.01 1.46 (1.24–1.70)
Ever smoked
Unvaccinated 261 (25) 176 (26) 152 (27) 55 (10) 52 (10) < 0.01 Ref
Vaccinated 443 (23) 330 (24) 296 (25) 125 (10) 107 (10) < 0.01 0.92 (0.79–1.09)
Ever used contraception
Unvaccinated 640 (64) 443 (68) 395 (71) 420 (75) 359 (75) < 0.01 Ref
Vaccinated 1380 (72) 1038 (78) 973 (81) 1020 (85) 889 (86) < 0.01 1.69 (1.45–1.97)
Ever had sex
Unvaccinated 525 (52) 390 (60) 362 (65) 383 (70) 349 (71) < 0.01 Ref
Vaccinated 1070 (56) 845 (64) 845 (71) 914 (76) 833 (80) < 0.01 (c1) 1.19 (1.02–1.39)
(c2) 1.30 (1.24–1.35)
(c3) 1.06 (1.00–1.12)
The p-value indicates whether there is a significant change over time. The OR indicates possible differences between vaccinated and unvaccinated participants
overall (across all five time points)
aLow/Middle = no/primary education, lower general to intermediate vocational secondary education; High = higher vocational/general secondary education,
(pre)university education
bPreviously published by Mollers et al. [17]
cSignificant interaction time and vaccination status; 1: OR for vaccination status at round one, 2: OR for round, 3: OR for interaction between vaccination status and round
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We did not find strong indications for a difference in
change in condom use between vaccinated and unvaccin-
ated over time as there were no differences in condom use
overall or with a casual partner. However, vaccinated
women were less likely to report to always use a condom
with their steady partner. In general, the decline in con-
dom use for both vaccinated and unvaccinated girls over
time might be explained by longer duration of relation-
ships and/or a switch to other contraceptives. Indeed, use
of contraceptives other than condoms, increased signifi-
cantly in both vaccinated and unvaccinated participants
over time (data not shown). Educating the adolescent
population on sexual risk remains of critical importance.
Previous studies on condom use and a possible difference
between vaccinated and unvaccinated women showed ei-
ther no difference in condom use [18, 23, 27–29] or a
higher condom use among vaccinated women [17, 22, 30,
31]. A recent systematic review incorporating 21 studies
Table 2 Univariable longitudinal analysis (using GEE) of sexual risk behavior factors among sexually active participants
Round 1a Round 2 Round 3 Round 4 Round 5
Category n (%) n (%) n (%) n (%) n (%) p-value OR (+ 95% CI) aORc (+ 95% CI)
Having had sex for the first time during previous 6 months
Unvaccinated – 84 (22) 71 (20) 69 (18) 59 (17) 0.01 Ref Ref
Vaccinated – 216 (26) 166 (20) 170 (19) 179 (21) < 0.01 1.15 (0.97–1.37) 1.14 (0.96–1.35)
Lifetime number of sexual partnersb (mean 95%CI)
Unvaccinated 2.2 (2.0–2.4) 2.5 (2.3–2.7) 2.7 (2.4–3.0) 3.0 (2.7–3.3) 3.4 (3.1–3.8) < 0.01 Ref Ref
Vaccinated 1.9 (1.8–2.0) 2.1 (2.0–2.3) 2.4 (2.3–2.6) 2.9 (2.7–3.1) 3.0 (2.8–3.2) < 0.01 − 0.20 (− 0.41–0.00)b −0.26 (− 0.46 – -0.05)
Having a steady partner at the moment
Unvaccinated 349 (67) 275 (71) 247 (68) 275 (72) 250 (72) 0.17 Ref Ref
Vaccinated 729 (68) 586 (69) 576 (68) 622 (68) 578 (69) 0.34 0.96 (0.82–1.13) 1.02 (0.87–1.19)
Having had a casual partner during previous 6 months
Unvaccinated 271 (52) 96 (25) 77 (21) 82 (22) 81 (23) < 0.01 Ref Ref
Vaccinated 512 (48) 163 (19) 170 (20) 234 (26) 189 (23) < 0.01 0.92 (0.80–1.06) 1.11 (0.96–1.29)
The p-value indicates whether there is a significant change over time. The OR indicates possible differences between vaccinated and unvaccinated participants
overall (across all five time points)
- Not asked in this round (Having had sex for the first time during previous 6 months was only questioned from round two onward)
aPreviously published by Mollers et al. [17]
bFor continuous variables, the mean difference was calculated. For other variables, odds ratios were calculated
cOR was adjusted for degree of urbanization and alcohol use
Table 3 Condom use with steady or casual partner among sexually active participants
Round 1a Round 2 Round 3 Round 4 Round 5 OR (+ 95% CI) aORb (+ 95%CI)
Category n (%) n (%) n (%) n (%) n (%) p-value
Always using a condom with steady partner during previous 6 months
Unvaccinated 67 (19) 59 (22) 41 (17) 40 (14) 34 (14) < 0.01 Ref Ref
Vaccinated 126 (17) 77 (13) 79 (14) 65 (10) 53 (9) < 0.01 0.71 (0.57–0.89) 0.71 (0.57–0.90)
Always using a condom with a casual partner during previous 6 months
Unvaccinated 75 (28) 27 (28) 17 (22) 27 (32) 20 (26) 0.12 Ref Ref
Vaccinated 144 (28) 50 (31) 51 (30) 67 (29) 44 (23) 0.97 1.00 (0.79–1.28) 1.00 (0.78–1.28)
Always using a condom during previous 6 months (combined for casual and steady partner)
Unvaccinated 93 (20) 75 (22) 56 (18) 59 (18) 50 (16) < 0.01 Ref Ref
Vaccinated 197 (21) 113 (17) 117 (16) 107 (14) 90 (12) 0.02 (c1) 1.01 (0.80–1.27) 0.85 (0.70–1.02)
(c2) 0.91 (0.85–0.99)
(c3) 0.91 (0.82–1.00)
The p-value indicates whether there is a significant change over time. The OR indicates possible differences between vaccinated and unvaccinated participants
overall (across all time points)
aPreviously published by Mollers et al. [17]
bOR adjusted for urbanisation degree and alcohol use
cSignificant interaction between time and vaccination status; 1: OR for vaccination status at round one, 2: OR for round 3, 3: OR for interaction between
vaccination status and round
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did not find evidence that sexual risk compensation or
disinhibition was associated with HPV vaccination [32].
Using data from insurance databases, Jena et al. also
observed that there was no association between HPV
vaccination and an increase in STI rates among 12 to
18 year-old females in the United States [33].
Vaccinated girls were more likely to be sexually active,
and this also increased more over time than among
unvaccinated girls in our study. The proportion of
sexually active vaccinated women in this age group was
comparable to what was observed in a representative
sample of the Netherlands in 2005 and 2012 (18–
20 years: 76 and 77%) [34, 35]. Also, when the model for
ever had sex was adjusted for other characteristics show-
ing a difference between vaccinated and unvaccinated
participants (urbanization degree, level of education and
Table 4 General knowledge (percentage with correct answer) on HPV and cervical cancer among vaccinated and unvaccinated
participants on the first and last rounds
Round 1a Round 5
Category n (%) n (%) p-value Mean difference (+ 95% CI)
General knowledge score (mean 95%CI)
Unvaccinated 4.25 (4.14–4.36) 4.70 (4.54–4.87) < 0.01 Ref
Vaccinated 4.29 (4.21–4.37) 4.92 (4.80–5.03) < 0.01 0.11 (− 0.02–0.23)
HPV infections are easily treatable (No)
Unvaccinated 142 (14) 96 (20)
Vaccinated 284 (15) 279 (27)
HPV infections are rare (No)
Unvaccinated 428 (42) 232 (48)
Vaccinated 882 (46) 554 (53)
An HPV infection always leads to cervical cancer (No)
Unvaccinated 690 (68) 389 (80)
Vaccinated 1294 (64) 844 (81)
Cervical cancer is always fatal (No)
Unvaccinated 835 (82) 427 (88)
Vaccinated 1579 (82) 923 (89)
Cervical cancer is easily treatable (No)
Unvaccinated 178 (18) 108 (22)
Vaccinated 408 (21) 273 (26)
Cervical cancer is a common disease (No)
Unvaccinated 237 (23) 116 (24)
Vaccinated 334 (17) 238 (23)
If you have unprotected sex, you are at high risk of an HPV infection (Yes)
Unvaccinated 732 (72) 345 (71)
Vaccinated 1411 (74) 782 (75)
An HPV infection is a risk for cervical cancer (Yes)
Unvaccinated 815 (80) 400 (82)
Vaccinated 1555 (81) 888 (85)
An HPV infection can cause genital warts (Yes)
Unvaccinated 193 (19) 134 (28)
Vaccinated 389 (20) 274 (26)
An HPV infection usually disappears on its own (Yes)
Unvaccinated 56 (6) 42 (9)
Vaccinated 80 (4) 61 (6)
Questions regarding general knowledge were only incorporated in the questionnaires of round one (first) and round five (last). The p-values of vaccinated and
unvaccinated girls indicate whether the knowledge changed over time within these groups
aPreviously published by Mollers et al. [17]
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contraceptive use), the adjusted OR was 1.03 (95%CI
0.89–1.19), indicating that there was no difference in the
proportion of participants ever had sex between the
vaccinated and unvaccinated participants. We found that
vaccinated girls who were sexually active reported a
lower number of lifetime sexual partners, and this
Table 5 Transmission knowledge (percentage of correct answers) among both vaccinated and unvaccinated participants in the first
and last rounds
Round 1a Round 5
Category n (%) n (%) p-value Mean difference (+ 95% CI)
Transmission knowledge score (mean 95%CI)
Unvaccinated 7.47 (7.39–7.55) 7.52 (7.40–7.63) 0.60 Ref
Vaccinated 7.39 (7.33–7.45) 7.53 (7.46–7.61) 0.01 0.01 (−0.10–0.10)
HPV can be transmitted by
Holding Hands (No)
Unvaccinated 1002 (99) 481 (99)
Vaccinated 1882 (99) 1034 (99)
Deep throat kissing (No)
Unvaccinated 911 (90) 449 (92)
Vaccinated 1711 (90) 968 (93)
Skin-to-skin contact (Yes)
Unvaccinated 95 (9) 36 (7)
Vaccinated 185 (10) 71 (7)
Stroking partner at genitals (Yes)
Unvaccinated 340 (34) 126 (26)
Vaccinated 587 (31) 258 (25)
Public toilet (No)
Unvaccinated 836 (83) 427 (88)
Vaccinated 1575 (82) 927 (89)
Unprotected oral sex (Yes)
Unvaccinated 631 (62) 294 (61)
Vaccinated 1219 (64) 640 (62)
Unprotected vaginal sex (Yes)
Unvaccinated 967 (95) 469 (96)
Vaccinated 1818 (95) 1004 (97)
Unprotected anal sex (Yes)
Unvaccinated 718 (71) 349 (70)
Vaccinated 1345 (70) 766 (71)
Sex with a condom (Yes)
Unvaccinated 156 (15) 95 (20)
Vaccinated 238 (12) 157 (15)
Sharing a spoon or cup (No)
Unvaccinated 962 (95) 464 (95)
Vaccinated 1777 (93) 999 (96)
Sneezing/coughing (No)
Unvaccinated 959 (95) 470 (97)
Vaccinated 1794 (93) 1010 (97)
Questions regarding transmission knowledge were only incorporated in the questionnaires of round one (first) and round five (last). The p-values of vaccinated and
unvaccinated indicate whether the knowledge changed over time within these groups
aPreviously published by Mollers et al. [17]
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difference did not change over time. Previously, several
studies examined the relationship between the number
of partners and HPV vaccination. Most of these studies
did not find an association between the number of part-
ners and vaccination status or observed a lower number
of partners among vaccinated women, which is in line
with our results [18, 21–23, 28–31, 36, 37].
We observed some differences between vaccinated and
unvaccinated participants in the degree of urbanization,
alcohol and contraceptive use, being sexually active, and
vaccination knowledge, but these differences did not
change over time. Given the vaccination uptake of approxi-
mately 50% for the first dose in these birth cohorts [38],
vaccinated and unvaccinated girls may differ by nature
prior to vaccination, and changes over time in behavior
among either group might reflect an impact of vaccination
or the influence of underlying differences between these
groups. Differences in these socio-demographics between
vaccinated and unvaccinated girls might lead to differences
in sexual behavior.
In general, we did not observe differences (over time) in
general HPV or transmission knowledge score between
vaccinated and unvaccinated individuals. However, HPV
knowledge in both vaccinated and unvaccinated girls
could be improved. These findings were mainly in line
with the studies of Lenselink et al. and Sopracordevole et
al. [39, 40]. We observed a small difference in the HPV
knowledge vaccination score between vaccinated and
unvaccinated participants; however, this difference
diminished during follow-up. In this respect, vaccinated
girls were less likely to know that HPV vaccination does
not protect against all HPV types (data not shown). It
will be worthwhile to focus specifically on this topic in
future communications, as it might influence participa-
tion in cervical cancer screening at a later age because
vaccinated women might think they are no longer at
risk.
Our study had some weaknesses and several strengths.
Unfortunately, the response rate was only 15%, and the
overall drop-out rate was 45%. Also, like as many other
studies questioning behavior, recall bias on sexual behav-
ior could have occurred in this study, although this is
unlikely to be different for vaccinated and unvaccinated
participants. While previous studies did not find evidence
for behavioral risk disinhibition following vaccination, this
might have been due to either the cross-sectional
design or the limited power. Our large prospective
study has now provided a much more robust basis for
the lack of association. The vaccination status of partic-
ipants was obtained from the Dutch vaccination regis-
try and not dependent on self-reporting. Another
strength is that we combined assessment of sexual be-
havior with assessment of participants’ knowledge on
HPV and transmission of HPV.
Conclusion
During our two-years of follow-up e found that vaccinated
girls were less likely to use a condom with their steady
Table 6 Knowledge of the consequences (percentage of correct answers) of HPV vaccination reported by vaccinated and
unvaccinated girls
Round 1a Round 2 Round 3 Round 4 Round 5
Category n (%) n (%) n (%) n (%) n (%) p-value Mean difference (+ 95% CI)
HPV vaccination score (mean 95%CI)
Unvaccinated 2.50 (2.45–2.54) 2.46 (2.40–2.52) 2.59 (2.53–2.65) 2.60 (2.54–2.65) 2.67 (2.62–2.73) < 0.01 Ref
Vaccinated 2.44 (2.41–2.47) 2.40 (2.36–2.43) 2.50 (2.46–2.53) 2.54 (2.51–2.57) 2.67 (2.64–2.71) < 0.01 (b1) -0.07 (−0.12–0.01)
(b2) 0.03 (0.02–0.04)
(b3) 0.02 (0.00–0.04)
Vaccination protects against all HPV types (No)
Unvaccinated 701 (70) 416 (63) 384 (69) 388 (69) 360 (75)
Vaccinated 1110 (58) 638 (48) 665 (55) 697 (58) 753 (73)
HPV vaccination protects against all STIs (No)
Unvaccinated 865 (86) 574 (88) 518 (93) 520 (93) 454 (95)
Vaccinated 1702 (89) 1246 (94) 1144 (95) 1159 (97) 1008 (97)
Condoms are not needed anymore once vaccinated (No)
Unvaccinated 939 (94) 623 (95) 542 (97) 545 (98) 468 (98)
Vaccinated 1842 (97) 1297 (98) 1187 (99) 1186 (99) 1016 (98)
The p-values of vaccinated and unvaccinated indicate whether the knowledge changed over time within these groups
aPreviously published by Mollers et al. [17]
bSignificant interaction between time and vaccination status; 1: difference for vaccination status at round one, 2: difference for round, 3: difference for interaction
between vaccination status and round
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partner, but comparable condom use was observed for
casual partners between vaccinated and unvaccinated
girls. The few observed differences between the groups
and the low knowledge in both groups on HPV underline
the importance for more attention to safe sex practices.
Our findings together with those from other previous
studies do not imply that vaccination status is related to
changes in sexual risk behavior hence, it is unlikely that
this might influence the effectiveness of the vaccination
program.
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